PDT Partners’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,009
Closed -$156K 1098
2022
Q2
$156K Sell
19,009
-1,975
-9% -$16.2K 0.01% 851
2022
Q1
$183K Buy
+20,984
New +$183K 0.02% 826